title: Nevirapine: new drug, new class, new questions.
authors.forename: M
authors.initials: M
authors.lastname: Mascolini
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D002648:Child; D016049:Didanosine / Q000008:administration & dosage; D017277:Drug Approval; D004359:Drug Therapy, Combination; D006678:HIV / Q000302:isolation & purification; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006801:Humans; D019829:Nevirapine; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration; D015215:Zidovudine / Q000008:administration & dosage
chemical_list: D000998:Antiviral Agents; D011725:Pyridines; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D019829:Nevirapine; D016049:Didanosine